Form 4: Applied Therapeutics Executive Sells Shares to Cover Tax Obligations

Adam Hansard, Chief Commercial Officer of Applied Therapeutics, sold 48,871 shares of common stock on March 14, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

• On March 14, 2024, Adam Hansard, the Chief Commercial Officer of Applied Therapeutics, Inc., sold 48,871 shares of the company's common stock.
• The shares were sold at a weighted average price of $5.39, with individual transactions ranging from $5.37 to $5.795.
• This sale was executed to cover tax withholding obligations associated with the vesting and settlement of compensatory Restricted Stock Units.
• Following the transaction, Hansard directly owns 732,919 shares of Applied Therapeutics.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover taxes). It's neutral in sentiment as it doesn't convey any positive or negative outlook for the company.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives. This transaction is not necessarily indicative of the executive's sentiment towards the company's future prospects.

Stakeholder Impact

• The sale of shares could have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely to be minimal given the relatively small number of shares sold.

Key Dates